Identification of a Putative Alphavirus Receptor on Mouse Neural Cells
Overview
Authors
Affiliations
Alphaviruses replicate in a wide variety of cells in vitro. The prototype alphavirus, Sindbis virus, causes an age-dependent encephalitis in mice and serves as an important model system for the study of alphavirus neurovirulence. To begin to understand the role of cellular virus receptors in the pathogenesis of Sindbis virus infection, we developed an anti-idiotypic antibody made in rabbits against a neutralizing monoclonal antibody specific for the E2 surface glycoprotein. The anti-idiotypic antibody (anti-Id 209) bound to N18 mouse neuroblastoma cells and inhibited adsorption of 35S-labeled virus by 50%. Binding of anti-Id 209 was inhibited by pretreatment of N18 cells with various proteases but not with neuraminidase or phospholipase, while virus binding was inhibited by pretreatment with phospholipase as well as protease. Anti-Id 209 precipitated proteins of 110 and 74 kDa from N18 cells intrinsically labeled with [35S]methionine. N18 cells grow with two phenotypes in culture, and immunoprecipitation of 125I-surface-labeled cells showed that the 74-kDa protein was present on loosely adherent cells growing in aggregates, while the 110-kDa protein was present in smaller amounts on firmly adherent cells growing as a monolayer. Analysis of brain cells from newborn mice by flow cytometry showed that all cells expressed the receptor protein at birth, but by 4 days after birth half of the cells had ceased receptor expression. A survey of other cell lines showed the protein to be present on murine fibroblastic and other rodent neuroblastoma cell lines but rarely on human neural or nonneural cell lines. These studies suggest that one of the receptors for Sindbis virus on mouse neural cells is a protein that is regulated during development of the nervous system. Developmental down-regulation of receptor protein expression may contribute to the age-dependent nature of susceptibility of mice to fatal alphavirus encephalitis.
A molecular understanding of alphavirus entry and antibody protection.
Kim A, Diamond M Nat Rev Microbiol. 2022; 21(6):396-407.
PMID: 36474012 PMC: 9734810. DOI: 10.1038/s41579-022-00825-7.
Prasad V, Blijleven J, Smit J, Lee K Nat Commun. 2022; 13(1):4772.
PMID: 35970990 PMC: 9378758. DOI: 10.1038/s41467-022-32431-9.
Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain.
Takenouchi A, Saito K, Saito E, Saito T, Hishiki T, Matsunaga T Pediatr Surg Int. 2015; 31(12):1151-9.
PMID: 26298056 DOI: 10.1007/s00383-015-3784-y.
Schultz K, Vernon P, Griffin D J Virol. 2014; 89(1):48-60.
PMID: 25320290 PMC: 4301127. DOI: 10.1128/JVI.02394-14.
Structural studies on antibody recognition and neutralization of viruses.
Smith T Curr Opin Virol. 2011; 1(2):150-6.
PMID: 21887208 PMC: 3163491. DOI: 10.1016/j.coviro.2011.05.020.